Results 241 to 250 of about 534,439 (293)

Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas

Chemical Reviews, 2016
Hong Liu, José Luis Aceña, Kunisuke Izawa   +2 more
exaly  

Chitosan Chemistry and Pharmaceutical Perspectives

Chemical Reviews, 2004
Kumar Ravi, Abraham Domb, H Sashiwa
exaly  

Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)

Chemical Reviews, 2014
Alexander E Sorochinsky, Hong Liu, Carlos del Pozo Losada   +2 more
exaly  

Contribution of Organofluorine Compounds to Pharmaceuticals

ACS Omega, 2020
Munenori Inoue, Norio Shibata, Yuji Sumii   +2 more
exaly  

The Committee on Pharmaceutical Research of the American Pharmaceutical Association

Science, 1944
openaire   +2 more sources

Immunomodulating Pharmaceuticals

2013
Gideon P. Smith, Edwin S.L. Chan
openaire   +1 more source

Application of ω-Transaminases in the Pharmaceutical Industry

Chemical Reviews, 2018
Brendan Gilmore, Christopher C.R. Allen, Thomas S Moody   +2 more
exaly  

Pharmaceutical Promotions

New England Journal of Medicine, 1992
openaire   +2 more sources

Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods

Chemical Reviews, 2019
Kishor K, Dinesh Mohan, Todd E Mlsna
exaly  

Pharmaceutical representatives

The Lancet, 1997
openaire   +2 more sources